RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Misty Eaton to Dose-Response Relationship, Drug

This is a "connection" page, showing publications Misty Eaton has written about Dose-Response Relationship, Drug.
Connection Strength

0.264
  1. Rivera-Aponte DE, M?ndez-Gonz?lez MP, Rivera-Pag?n AF, Kucheryavykh YV, Kucheryavykh LY, Skatchkov SN, Eaton MJ. Hyperglycemia reduces functional expression of astrocytic Kir4.1 channels and glial glutamate uptake. Neuroscience. 2015 Dec 03; 310:216-23.
    View in: PubMed
    Score: 0.109
  2. Eaton MJ, Lookingland KJ, Moore KE. The sigma ligand rimcazole activates noradrenergic neurons projecting to the paraventricular nucleus and increases corticosterone secretion in rats. Brain Res. 1996 Sep 16; 733(2):162-6.
    View in: PubMed
    Score: 0.029
  3. Eaton MJ, Lookingland KJ, Moore KE. The sigma receptor ligand rimcazole alters secretion of prolactin and alpha-melanocyte stimulating hormone by dopaminergic and non-dopaminergic mechanisms. Eur J Pharmacol. 1996 Mar 28; 299(1-3):171-7.
    View in: PubMed
    Score: 0.028
  4. Eaton MJ, Lookingland KJ, Moore KE. Effects of the selective dopaminergic D2 agonist quinelorane on the activity of dopaminergic and noradrenergic neurons projecting to the diencephalon of the rat. J Pharmacol Exp Ther. 1994 Feb; 268(2):645-52.
    View in: PubMed
    Score: 0.024
  5. Eaton MJ, Moore KE, Lookingland KJ. Differential effects of the D2 receptor agonist quinelorane on the secretion of prolactin and alpha-melanocyte-stimulating hormone. Life Sci. 1993; 53(2):107-12.
    View in: PubMed
    Score: 0.023
  6. Eaton MJ, Tian Y, Lookingland KJ, Moore KE. Comparison of the effects of remoxipride and raclopride on nigrostriatal and mesolimbic dopaminergic neuronal activity and on the secretion of prolactin and alpha-melanocyte-stimulating hormone. Neuropsychopharmacology. 1992 Nov; 7(3):205-11.
    View in: PubMed
    Score: 0.022
  7. Eaton MJ, Tian Y, Lookingland KJ, Moore KE. Remoxipride and raclopride differentially alter the activity of incertohypothalamic dopaminergic neurons. Neuropharmacology. 1992 Nov; 31(11):1121-6.
    View in: PubMed
    Score: 0.022
  8. Tian Y, Eaton MJ, Goudreau JL, Lookingland KJ, Moore KE. Neurochemical evidence that 5-hydroxytryptaminergic neurons tonically inhibit noradrenergic neurons terminating in the hypothalamus. Brain Res. 1993 Apr 02; 607(1-2):215-21.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support